| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Ops &Clinical Research | Chief Operating Officer
1 company
Sampath Anand is an EVP, Ops &Clinical Research at MASIMO CORP. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $8.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | MASI Masimo Corp | EVP, Ops &Clinical Research | Sale+OE | 18,680 | $136.81 | $2,555,570.28 | -12.6% | +29.7% | - | |
| Dec 15, 2020 | MASI Masimo Corp | EVP, Ops &Clinical Research | Sale+OE | 30,000 | $265.59 | $7,967,805.00 | -52.1% | - | - | |
| Apr 13, 2020 | MASI Masimo Corp | EVP, Ops &Clinical Research | Sale+OE | 19,796 | $180.00 | $3,563,280.00 | -59.0% | - | - | |
| Nov 20, 2019 | MASI Masimo Corp | EVP, Ops &Clinical Research | Sale+OE | 15,000 | $155.00 | $2,325,001.50 | -54.5% | - | - | |
| Jun 14, 2019 | MASI Masimo Corp | EVP, Ops &Clinical Research | Sale+OE | 30,000 | $142.39 | $4,271,550.00 | -54.5% | - | - | |
| Jan 15, 2019 | MASI Masimo Corp | Chief Operating Officer | Sale+OE | 30,000 | $115.00 | $3,450,000.00 | -70.6% | - | - | |
| Nov 28, 2018 | MASI Masimo Corp | Chief Operating Officer | Sale+OE | 30,000 | $110.00 | $3,300,000.00 | -72.7% | - | - | |
| Jul 11, 2017 | MASI Masimo Corp | Chief Operating Officer | Sale+OE | 40,000 | $92.00 | $3,680,000.00 | -66.7% | - | - | |
| Nov 1, 2016 | MASI Masimo Corp | Chief Operating Officer | Sale+OE | 65,000 | $55.04 | $3,577,683.20 | -100% | - | - | |
| Nov 6, 2015 | MASI Masimo Corp | Chief Operating Officer | Sale+OE | 45,000 | $42.00 | $1,890,000.00 | -100% | - | - |